Abstract Introduction: Reports of actual pediatric organ donor management practice among US organ procurement organizations are sparse, and the use of standardized management guidelines is unknown. A recent consensus statement from the Society of Critical Care Medicine, the American College of Chest Physicians, and the Association of Organ Procurement Organizations offers guidelines for the management of the pediatric organ donor. Research Question: To describe the use of guidelines and routine practices in the management of the pediatric organ donor with respect to hemodynamics, lung and ventilator management, fluid and electrolytes, hormonal replacement therapy, the use of blood products, thermoregulation, and prophylactic antibiotics. Design: Cross-sectional observational study using a survey and follow-up telephone interview with respondents from all 58 US organ procurement organizations. Results: All 58 US Organ Procurement Organizations participated. A majority employed written guidelines for the management of pediatric donor hemodynamics, thermoregulation, fluids, and electrolytes. Management of blood products, the lung, and mechanical ventilation were less commonly committed to written guidelines, but common practices were described. All used various forms of hormonal replacement therapy and the majority administered empiric antibiotic therapy. Wide variation was observed in the management of the lung, mechanical ventilation, and glycemic control. Discussion: Most OPOs used forms of standardized donor management for the pediatric organ donor although variation in the content of that management exists. Barriers to an evidence-based approach to the pediatric donor need to be determined and addressed.
Introduction
Organ procurement through donation after neurologic determination of death (DNDD) is the primary source of viable solid organs for the over 116,000 patients awaiting a life-saving transplantation in the United States. However, data from the Organ Procurement and Transplantation Network indicate a persistent gap between the number of DNDD organs recovered and the number needed for transplantation. 1 Intensive management of the deceased organ donor is essential to maximize the number of DNDD organs recovered, optimize the physiology of those organs, and increase the likelihood of adequate posttransplant organ function. 2 Standardized donor management focuses donor care on the transplantable organs and the physiologic derangements associated with brain death. In adults, standardized protocols or management guidelines have been shown to increase the overall number of organs transplanted from DNDD donors. 3, 4 A recently published consensus statement by the Society of Critical Care Medicine, American College of Chest Physicians, and Association of Organ Procurement Organizations on management of the potential organ donor includes recommendations for hemodynamics, lung recruitment and mechanical ventilation, fluids/electrolytes, endocrine dysfunction, blood product utilization, and thermoregulation. 5 Specific donor management practices including control of serum glucose, serum sodium, and use of hormonal resuscitation have been shown to increase the number of transplantable organs without worsening graft function. [6] [7] [8] Little evidence-based research has been published regarding protocols or specific management practices for pediatric organ donors. Although DNDD pediatric donors typically comprise only 9% to 11% of all DNDD donors, they help to reduce the organ shortage for all on the wait list and in particular those under 1 year of age whose mortality is proportionally higher than any other age-group. 9 Katz et al described a pressor effect from low-dose vasopressin infusions in a retrospective analysis of pediatric donors with diabetes insipidus that resulted in faster weaning from vasopressors compared with a control cohort. 10 A retrospective cohort study of a standardized thyroxine (T4) infusion similarly reduced vasopressor needs in DNDD children during donor management. 11 Recommendations for care of the pediatric organ donor have been described in reviews and summarized in a recent consensus statement (see Table 1 ).
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Specific Aim
A previous study by the authors focused on the general process of pediatric organ donor management by US Organ Procurement Organizations (OPOs) including the various definitions of "pediatric," the use of donor management goals, and the use of intensive care consultation in the care of the DNDD pediatric organ donor.
14 This article will examine the evidence for standardized pediatric donor management among US OPOs with respect to hemodynamics; lung and mechanical ventilator management; fluid, electrolytes, and nutrition; hormonal replacement therapy; the use of blood products, thermoregulation, and prophylactic antibiotics.
Methods Design
The study involved a 36-question online survey and follow-up telephone interview regarding pediatric donor management by US OPOs. Additional questions for clarification of survey or interview answers were conveyed by e-mail. The protocol was reviewed and approved by the institutional review board (IRB), which waived the requirement for informed consent due to the minimal risk to the OPOs and their staff.
Setting and Population
In May 2013, the chief executive officer or director of organ procurement at each of the 58 US OPOs was contacted by mail and asked to identify an individual (respondent) within their organization knowledgeable and willing to participate. The OPOs not responding to biweekly e-mail requests were telephoned directly. Organ Procurement Organizations were assured that they would not be identified in any publication by name and that no identifiable information would be released without their permission.
Data Collection
The survey and interview queried the use of blood pressure goals, measurements of perfusion, vasoactive infusions, hemodynamic monitoring, protocols for ventilator and lung management, pharmacologic treatment of pulmonary edema, inhaled medications, fluid management protocols, serum sodium thresholds, low-dose dopamine, nutrition, empiric vasopressin infusions, guidelines for glycemic control, thyroid replacement therapy, steroid therapy, blood product transfusion thresholds, temperature regulation, and empiric antibiotic therapy. In the absence of written guidelines, respondents were queried regarding the routine practice within their OPO, defined by a practice they would expect to occur 85% of the time.
Data Analysis
Data were analyzed using SPSS software, version 12.0 (Chicago, Illinois). Responses to questions were summarized by descriptive statistics; percentages for categorical variables; and mean, standard deviation (SD), and range for continuous variables.
Procedure
The survey was developed following a literature search and discussions with pediatric intensivists, transplant surgeons, OPO administrators, and organ procurement specialists. A table of specifications was constructed to ensure that relevant aspects of pediatric donor management were addressed. A draft survey was created in a web-based format (Qualtrics Survey Software, http://www.research@qualtrics.com) and underwent pilot testing by staff from 4 OPOs. Pilot participants completed a postsurvey questionnaire focusing on the survey length, clarity, content validity, and improvements necessary to maximize the response rate and quality of a revised survey. A follow-up telephone interview was scheduled upon completion of the survey to enhance the accuracy and consistency of survey answers and provide an opportunity for discussion of management practices. A neutral observer who was present during the interviews with pilot study participants provided feedback to the interviewer regarding clarity, pace of the interview, and the avoidance of bias. Following revisions to the survey, OPO respondents were contacted (recontacted in the case of pilot study participants) and given links to the survey site.
Results
Organ procurement organizations Response
Respondents from all 58 OPOs in the United States and Puerto Rico completed the survey and participated in the follow-up telephone survey for a 100% response rate.
Hemodynamics
A majority of OPOs (43/58, 84%) followed written and standardized guidelines for determining the age-appropriate blood pressure in the pediatric donor. The use of specific hemodynamic monitoring practices is shown in Figure 1 . Dopamine was the most commonly employed initial vasoactive infusion for hypotension (24/58, 41%) followed by phenylephrine (8/58, 14%), epinephrine (4/58, 7%), norepinephrine (2/58, 3%), vasopressin (1/58, 2%), and dobutamine (1/58, 2%). Nearly one-third of OPOs (18/58, 31%) indicated that they did not routinely favor any 1 medication for hypotension.
Lung and Mechanical Ventilator Management
Fewer than half of US OPOs (21/58, 36%) used standardized guidelines or protocols for management of the lung and/or mechanical ventilation. Most OPOs (31/58, 53%) routinely targeted a specific tidal volume for donors using either pressure-or volume-limited mechanical ventilation ( Figure 2 ), although 25 (43%) of 58 had no regular strategy and 2 (3%) routinely initiated airway pressure release ventilation following authorization. Respondents from 15 (26%) OPOs indicated that they routinely used specific lung recruitment techniques including increased positive end-expiratory pressure (9 OPOs), breath holds (5 OPOs), aggressive chest physiotherapy (5 OPOs), a modified San Antonio lung transplant protocol (4 OPOs), sigh breaths (3 OPOs), early/more frequent bronchoscopy (2 OPOs), airway pressure release ventilation (2 OPOs), and/or prone positioning (1 OPO). Thirty-four (59%) OPOs had written guidelines or orders specifying head of the bed elevation (20 -30 ) to reduce contamination of the donor lung. Most OPOs (41/58, 71%) empirically administered inhaled medications to their pediatric donors in the following forms: albuterol (24/41, 59%); albuterol and ipratropium bromide (15/41, 37%); albuterol and beclomethasone (1/41, 2%); and albuterol and budesonide (1/41, 2%). Pediatric organ donors with pulmonary edema and reduced compliance were administered neuromuscular blockade to eliminate spinal reflexes and potential elevations in airway pressure (7/58, 12%), naloxone (18/58, 31%), and/or additional systemic steroids (3/58, 5%).
Fluid, Electrolytes, and Nutrition
Respondents indicated that standardized guidelines for fluid and electrolyte management of the pediatric organ donor were used by 31 (53%) of 58 OPOs. Routine use of serum sodium thresholds was specified by 52 (90%) of 58 OPOs; 160 meq/L was used by 18 OPOs, 155 meq/L by 30 OPOs, and 150 meq/L by 4 OPOs. Written guidelines for glycemic control had been established at 29 (50%) of 58 OPOs. Responses to the routine definition of hypoglycemia (20 responses) averaged 69 (SD 12) mg/ dL, range: 40-90 mg/dL) and for hyperglycemia (33 responses) averaged 171 (SD 37) mg/dL, range: 120-300 mg/dL). Written guidelines regarding nutrition were addressed by 3 (5%) of 58 OPOs. The majority of OPOs (53/58, 91%) routinely stopped all nutrition (enteral and parenteral) unless instructed otherwise by a transplant center. One respondent indicated that their OPO did not stop parenteral nutrition on neonates and 4 noted that they did not stop enteral nutrition on pediatric organ donors.
Hormonal Replacement Therapy
All 58 OPOs used forms of hormonal replacement therapy in the management of the pediatric organ donor, although this usage was either situational or empiric. The empiric use of vasopressin or similar analogs (regardless of evidence for diabetes insipidus) was employed by 21 (36%) of 58 OPOs. The administration of systemic steroids was a more common practice (57/58 OPOs, 98%). Methylprednisolone was the preferred steroidal preparation (51/57 OPOs, 89%), although hydrocortisone was used by 5 OPOs (9%) and 1 OPO used both steroids in combination. Methylprednisolone was most often administered by scheduled, interval dosing (32/52 OPOs, 62%) followed by single-dose administration (17/52 OPOs, 33%) and continuous infusion (2/52 OPOs, 4%); the methylprednisolone regimen used by the remaining OPO was unknown. Comparative steroid dosing among 50 OPOs that empirically administered systemic steroids is illustrated in Figure 3 (the dosing used by 5 OPOs was unknown, 2 OPOs indicated the dosing was determined by the pediatric intensivist and hospital pharmacy, and 1 OPO did not empirically administer steroids). Empiric thyroid hormone was administered to pediatric organ donors by 37 (64%) of 58 OPOs; 19 (33%) of 58 OPOs reserved this form of hormone replacement therapy for low cardiac output and/or potential heart donors; and 2 (3%) of 58 OPOs did not administer thyroid hormone during pediatric organ donor management. The majority of OPOs (51/56, 91%) that administered thyroid hormone, either empirically or situationally, used thyroxine (T4) alone. A respondent from 1 OPO indicated that they primarily used triiodothyronine (T3) and 4 respondents indicated that they used a combination of the 2 thyroid hormones. The most common T4 dosing (25/51, 49%) adhered largely to the regimen described by Zuppa et al: an age-dependent bolus dose followed by an infusion titrated between 0.8 and 1.4 mg/kg/ h. 11 The T4 dosing regimen for 10 (20%) of 51 OPOs was either unknown or determined by the pediatric intensivist or transplant surgeon; the remaining 16 (31%) of 51 OPOs used a variety of T4 bolus and infusion protocols.
Blood Products
Twenty-six respondents (26/58, 45%) answered that their OPO maintained standardized guidelines for red cell transfusion practice; an additional 5 respondents provided information on routine practice. The transfusion threshold for hemoglobin was 8.8 g/dL (standard deviation [SD]: 1.2 g/dL, range: 7-10 g/dL, n ¼ 24) and for hematocrit was 26.8% (SD: 3.1%, range: 20-30%, n ¼ 18). Twelve OPOs (12/58, 21%) indicated that the transfusion threshold was lowered for infants under 4 months of age. In the absence of bleeding, 15 (26%) of 58 OPOs have a standardized threshold for transfusion of platelets that averaged 41 Â 10 3 /mL (SD: 23 Â 10 3 , range: 20-80 Â 10 3 /mL, n ¼ 15).
Thermoregulation
Forty-three OPOs (43/58, 74%) had standardized guidelines for temperature regulation of the pediatric organ donor. Eighteen respondents provided detailed information on their lower temperature limit that averaged 36.0 C (SD: 0.3 C, range: 35.4 C-36.7 C) and upper temperature limit that averaged 37.7 C (SD: 0.4 C, range: 37.0 C-38.3 C).
Empiric Antibiotics
Respondents indicated that 56 (97%) of 58 OPOs routinely administered antibiotics to all pediatric organ donors. The antibiotics empirically used in the absence of infection are displayed in Table 2 . 
Organ-Specific Practices
Thirteen (22%) respondents answered that likely pediatric heart donors were routinely treated differently by their OPO. These differences included the empiric use and longer duration of thyroid hormone; a preference for T3 over T4 thyroid hormone; the limitation of vasopressors; an earlier and more frequent use of echocardiography; greater attention to circulating volume and serum sodium, and an allowance for longer management time prior to organ recovery. Pediatric lung donors were routinely managed differently from other pediatric organ donors by 23 OPOs (40%). The different management of pediatric lung donors pertained primarily to less fluid and preference for lower central venous pressures; aggressive lung recruitment; early and frequent bronchoscopy; greater consultation with transplant centers, pediatric intensivists, and respiratory therapy; more thoracic imaging and blood gases; more time allocated to donor management; more frequent use of inhaled medications, a greater use of naloxone, and more deliberate and aggressive weaning of FIO 2 . Routine management of the likely pediatric kidney donor was modified by 9 (16%) of 58 OPOs. These modifications included the empiric use of lowdose dopamine, the limitation of high-dose vasopressors (particularly norepinephrine and vasopressin), more attention to maintaining volume status and urine output, and a greater use of pediatric intensive care consultation. Respondents from 6 (10%) of 58 OPOs indicated that routine management of the potential pediatric liver donor is handled differently from other donors. These differences included greater attention to serum sodium thresholds, avoidance of thyroid hormone, a limitation of high-dose vasopressors (particularly vasopressin), an initiation or continuation of enteral feeds (particularly for donors with a long intensive care course), and a greater use of pediatric intensive care consultation.
Discussion
This study offers a unique and detailed examination of pediatric organ donor management across the United States, with 100% participation of all 58 federally regulated OPOs. We noted a majority of OPOs had standardized guidelines for age-appropriate blood pressure and regularly incorporated both arterial and central venous pressure monitoring in the care of the pediatric organ donor. The management of fluids, electrolytes, and nutrition for the pediatric organ donor was facilitated by standardized guidelines at over half of OPOs, although routine serum sodium and glucose thresholds tended to exceed consensus recommendations. 5 However, standardized management of the lung and mechanical ventilation were used by a minority of OPOs, and routine practices for choosing a tidal volume, lung recruitment strategy, nebulized medication, and treating neurogenic pulmonary edema varied considerably. All OPOs engaged in some form of hormonal replacement therapy for pediatric organ donors with the empiric administration of systemic steroids used by all but 1 OPO and the empiric administration of thyroid hormone used by nearly two-thirds of OPOs. Thermoregulation was also dictated by written guidelines at a majority of OPOs and was generally consistent with consensus recommendations for pediatric organ donors. 5 Both developmental considerations and the frequency of cardiovascular instability may explain the larger percentage of pediatric hemodynamic guidelines developed by OPOs relative to guidelines for managing other organ systems. 13 Sustained hypotension was common in 1 pediatric series, and inadequate resuscitation may affect the number of transplantable organs and posttransplant organ function. 15 Aggressive circulatory resuscitation in adults increased the number of transplantable organs. [3] [4] Dopamine may exert added beneficial effects, as even low-dose infusions were found to reduce posttransplant dialysis. 16 Currently, there are no specific pediatric recommendations regarding the choice of catecholamines, although dopamine is often favored as a first choice in DNDD due to its potential influence on both cardiac output and systemic vascular resistance. 5 Measurements of perfusion such as serum lactate concentrations and venous oximetry may be useful guides for hemodynamic management that were infrequently used by OPOs. 13 The use of standardized fluid and electrolyte management protocols for the pediatric organ donor by a majority of OPOs may reflect again developmental considerations, as well as the propensity for diabetes insipidus and severe electrolyte derangements in this population. 15, 17 Routine avoidance of hypernatremia in pediatric organ donors was common among OPOs, although most have higher tolerances for serum sodium than those described in the consensus recommendations, perhaps reflecting the tolerances of local transplant centers and/or recent transplantation success with hypernatremic donors. 18 Routine practices for glucose control in pediatric donors were quite varied among OPOs with most definitions for hyperglycemia exceeding the consensus recommendations of 150 mg/ dL. The higher tolerance for hyperglycemia may reflect unitbased practices, the greater likelihood of hypoglycemia from tight glucose control in infants and children and/or emerging evidence for optimal glucose thresholds in adults. 6, 19 Although continued nutritional support of the potential liver donor has been recommended as potentially beneficial in optimizing glycogen stores (if otherwise not contraindicated), few OPOs routinely continued or started nutrition unless instructed by the transplant center. 5, 20 A minority of OPOs have developed standardized protocols for the management of the lungs and mechanical ventilation of the pediatric organ donor. This may reflect a greater reliance upon hospital-based pediatric intensivists and respiratory therapists for lung and ventilator management. Standardized lung management protocols in adults have been associated with increases in lung donors and transplants without compromising recipient outcomes. 21 The frequent target of tidal volumes in the 8 to 10 mL/kg range reflected the consensus recommendations, although smaller tidal volumes were also noted. 5 Lung protective strategies, which include lower tidal volumes, have also been shown to increase the number of lungs transplanted while preserving 6-month survival rates of recipients. 22 Although corticosteroid use has been shown to reduce lung water in adults, high-dose regimens have not been shown to improve the number of lungs transplanted or donor lung function over low-dose regimens. 23, 24 Both naloxone and inhaled albuterol have reported salutary effects on lung water and pulmonary edema, although studies in DNDD adults have not shown benefit. 25, 26 Hormone replacement therapy was commonly used in pediatric donor management despite a paucity of supporting data. Nearly all OPOs administered empiric corticosteroids in accordance with the adult data showing reduced lung water and possible benefits to hemodynamics, organ recovery, and graft function. 23, 27 Thyroid hormone replacement used empirically by almost two-thirds of OPOs has been shown to reduce the inotropic support required in pediatric DNDD.
11 Consensus recommendations to consider thyroid hormone, particularly in the pediatric donor requiring hemodynamic support, stems from adult studies demonstrating an increase in organs transplanted per donor and in the total number of organs transplanted. 5, 8 All OPOs used vasopressin or an analog to treat diabetes insipidus, but over one-third began an empiric infusion in pediatric organ donors. Katz et al demonstrated that low-dose vasopressin enabled a reduction in inotropic support without degrading posttransplant organ function. 10 The use of hormone replacement therapy and judicious fluid management (central venous pressures < 10 mm Hg) has been shown to significantly increase the utilization of heart, lung, and pancreas without negatively impacting recovery or transplantation of the liver or kidneys. 28 Red cell transfusion practices were codified by approximately half of US OPOs and ranged higher than the recommended 7 g/dL. 5 The recommendation was consistent with commonly applied transfusion thresholds for critically ill children, although may be conservative for infants <4 months of age where a hematocrit >30% to 35% may be more appropriate. 29 Most OPOs may have adopted more liberal transfusion practices to compensate for blood draw requirements during management and at the time of recovery. Red cell transfusion in DNDD adults has been associated with an apparent decrease in delayed graft function among renal graft recipients. 30 The majority of OPOs used written guidelines for thermoregulation in the pediatric DNDD donor that were similar to the temperature ranges recommended in the consensus recommendations. 5 However, emerging adult data may signal a role for the use of lower temperatures in DNDD donors due to an apparent reduction in delayed graft function among kidney recipients. 31 A study of therapeutic hypothermia in severe traumatic brain injury in children showed no significant increase in bleeding, infection, or arrhythmias in the treatment group. 32 This study was based upon answers to survey/interview questions and was therefore subject to flaws in sampling, content validity, and reliability. Sampling error was managed by achievement of a 100% response from OPOs, although not all questions were answered by every OPO. Content validity was enhanced through a vetting process that included both queries of interest groups and administering both the survey and interview in a pilot study. The use of a follow-up interview increased the reliability of the survey answers and provided the authors with insight regarding OPO practices. A previous study by the authors demonstrated the infrequent measurement of compliance to donor management guidelines.
14 Compliance with guidelines was not measured by this study; rather, the focus was on the availability and content of guidelines or routine practice used by the OPO.
The results of this study showed that there was considerable variance in the content of guidelines or routine practice for pediatric organ donor management. The variance is perhaps expected due to a lack of definitive evidence for best practices to emerge. The lack of evidence needs to be addressed through investigations that permit assessment of guideline efficacy with regard to both organ yield and function. Given the relatively small number of pediatric donors in the United States, the achievement of such assessment information will depend on collaboration among OPOs. The work of such collaboratives should address questions such as "What are the best practices for assuring adequacy of tissue perfusion and optimal lung recruitment in the pediatric donor?" or "Are novel techniques such as therapeutic hypothermia useful in pediatric organ donor cases?" The variance in OPO practices as reported in this article suggests the answers to these questions and others are unknown. Without new evidence, recommendations for optimal pediatric organ donor management cannot be updated and best practices disseminated.
